Soria is a consultant/advisory board member for AstraZeneca ,
Lefebvre Development of methodology Lefebvre Acquisition of data (provided animals, acquired and managed patients, provided facilities Lacroix Analysis and interpretation of data (e.g., statistical analysis, biostatistics, computational analysis ,
Lefebvre Administrative, technical, or material support (i.e., reporting or organizing data, constructing databases) Detecting somatic point mutations in cancer genome sequencing data: a comparison of mutation callers, Genome Med, vol.5, p.91, 2013. ,
Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?, Annals of Oncology, vol.25, issue.12, pp.2304-2317, 2014. ,
DOI : 10.1093/annonc/mdu480
Detection of circulating tumor DNA in early-and late-stage human malignancies, Sci Transl Med, vol.6, pp.224-248, 2014. ,
Circulating mutant DNA to assess tumor dynamics, Nature Medicine, vol.3, issue.9, pp.985-90, 2008. ,
DOI : 10.1038/nm.1789
Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer, PLOS ONE, vol.34, issue.2, p.108247, 2015. ,
DOI : 10.1371/journal.pone.0108247.t002
Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA, Cancer Discovery, vol.4, issue.6, pp.650-61, 2014. ,
DOI : 10.1158/2159-8290.CD-13-1014
Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing, Science Translational Medicine, vol.2, issue.20, pp.20-34, 2010. ,
DOI : 10.1126/scitranslmed.3000702
Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors, Genes, Chromosomes and Cancer, vol.15, issue.11, pp.1062-1071, 2010. ,
DOI : 10.1002/gcc.20815
Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial, Clinical Cancer Research, vol.22, issue.12, pp.2960-2968, 2016. ,
DOI : 10.1158/1078-0432.CCR-15-2470
Signatures of mutational processes in human cancer, Nature, vol.27, issue.7463, pp.415-436, 2013. ,
DOI : 10.1038/nature12477
Combining tumor genome simulation with crowdsourcing to benchmark somatic single-nucleotide-variant detection, Nature Methods, vol.9, issue.7, pp.623-653, 2015. ,
DOI : 10.1073/pnas.1530509100
THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL, Biometrika, vol.26, issue.4, pp.404-417, 1934. ,
DOI : 10.1093/biomet/26.4.404
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER), The Lancet Oncology, vol.15, issue.3, pp.267-74, 2014. ,
DOI : 10.1016/S1470-2045(13)70611-9
Fast and accurate long-read alignment with Burrows-Wheeler transform, Bioinformatics, vol.26, issue.5, pp.589-95, 2010. ,
DOI : 10.1093/bioinformatics/btp698
The Sequence Alignment/Map format and SAMtools, Bioinformatics, vol.25, issue.16, pp.2078-2087, 2009. ,
DOI : 10.1093/bioinformatics/btp352
A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff, Fly, vol.8, issue.2, pp.80-92, 2012. ,
DOI : 10.1101/gr.4086505
A statistical method for the detection of variants from next-generation resequencing of DNA pools, Bioinformatics, vol.26, issue.12, pp.318-342, 2010. ,
DOI : 10.1093/bioinformatics/btq214
An integrated map of genetic variation from 1,092 human genomes, Nature, vol.491, pp.56-65, 2012. ,
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data, Genome Research, vol.20, issue.9, pp.1297-303, 2010. ,
DOI : 10.1101/gr.107524.110
COSMIC: exploring the world's knowledge of somatic mutations in human cancer, Nucleic Acids Research, vol.43, issue.D1, pp.805-816, 2015. ,
DOI : 10.1093/nar/gku1075
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples, Nature Biotechnology, vol.27, issue.3, pp.213-222, 2013. ,
DOI : 10.1038/nature09515
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing, Genome Research, vol.22, issue.3, pp.568-76, 2012. ,
DOI : 10.1101/gr.129684.111
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer, New England Journal of Medicine, vol.368, issue.13, pp.1199-209, 2013. ,
DOI : 10.1056/NEJMoa1213261
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data, The Lancet Oncology, vol.15, issue.4, pp.406-420, 2014. ,
DOI : 10.1016/S1470-2045(14)70069-5